Folgen
Xuexin Li (李薛鑫)
Xuexin Li (李薛鑫)
China Medical University, Karolinska Institute
Bestätigte E-Mail-Adresse bei ki.se
Titel
Zitiert von
Zitiert von
Jahr
Magnetic nanoparticles for cancer theranostics: Advances and prospects
X Li, W Li, M Wang, Z Liao
Journal of Controlled Release 335, 437-448, 2021
1682021
mRNA vaccine in cancer therapy: Current advance and future outlook
Y Li, M Wang, X Peng, Y Yang, Q Chen, J Liu, Q She, J Tan, C Lou, Z Liao, ...
Clinical and Translational Medicine 13 (8), e1384, 2023
582023
Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives
JR Lin, ZT Wang, JJ Sun, YY Yang, XX Li, XR Wang, Y Shi, YY Zhu, ...
World Journal of Diabetes 13 (4), 308, 2022
312022
Endogenous stimuli-responsive nanoparticles for cancer therapy: from bench to bedside
F Xie, M Wang, Q Chen, T Chi, S Zhu, P Wei, Y Yang, L Zhang, X Li, ...
Pharmacological Research 186, 106522, 2022
262022
HTCA: a database with an in-depth characterization of the single-cell human transcriptome
L Pan, S Shan, R Tremmel, W Li, Z Liao, H Shi, Q Chen, X Zhang, X Li
Nucleic Acids Research 51 (D1), D1019-D1028, 2023
222023
Single-cell transcriptomic architecture unraveling the complexity of tumor heterogeneity in distal cholangiocarcinoma
H Li, L Qu, Y Yang, H Zhang, X Li, X Zhang
Cellular and Molecular Gastroenterology and Hepatology 13 (5), 1592-1609. e9, 2022
222022
Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy
X Peng, J Fang, C Lou, L Yang, S Shan, Z Wang, Y Chen, H Li, X Li
Acta Pharmaceutica Sinica B, 2024
212024
Universal cutoff for tumor mutational burden in predicting the efficacy of anti-PD-(L) 1 therapy for advanced cancers
SF Mo, ZZ Cai, WH Kuai, X Li, YT Chen
Frontiers in Cell and Developmental Biology 11, 1209243, 2023
172023
Single Cell Atlas: a single-cell multi-omics human cell encyclopedia
L Pan, P Parini, R Tremmel, J Loscalzo, VM Lauschke, BA Maron, P Paci, ...
Genome Biology 25 (1), 104, 2024
142024
A Guillain-Barre syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides
AAD Sheikh, S Gomaa, X Li, M Routledge, K Saigoh, N Numoto, T Angata, ...
Journal of Autoimmunity 116, 102571, 2021
132021
Immunotherapy in gastrointestinal cancers: advances, challenges, and countermeasures
ZX Wang, YQ Pan, X Li, T Tsubata, RH Xu
Science bulletin 68 (8), 763-766, 2023
122023
Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET
DC Kanellis, A Zisi, Z Skrott, B Lemmens, JA Espinoza, M Kosar, ...
Cell Death & Differentiation 30 (7), 1666-1678, 2023
82023
Management of the COVID-19 pandemic in Singapore from 2020 to 2021: a revisit
Z Liao, D Menon, L Zhang, YJ Lim, W Li, X Li, Y Zhao
Reports 5 (3), 35, 2022
82022
Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma
WF Hong, F Zhang, N Wang, JM Bi, DW Zhang, LS Wei, ZT Song, GB Mills, ...
Drug Resistance Updates 76, 101115, 2024
42024
A single-cell pan-cancer analysis to show the variability of tumor-infiltrating myeloid cells in immune checkpoint blockade
W Li, L Pan, W Hong, F Ginhoux, X Zhang, C Xiao, X Li
Nature Communications 15 (1), 6142, 2024
32024
Modulator of TMB-associated immune infiltration (MOTIF) predicts immunotherapy response and guides combination therapy
ZY Qian, YQ Pan, XX Li, YX Chen, HX Wu, ZX Liu, M Kosar, J Bartek, ...
Science Bulletin 69 (6), 803-822, 2024
32024
Harnessing the potential of spatial multiomics: a timely opportunity
X Li
Signal Transduction and Targeted Therapy 8 (1), 234, 2023
32023
The Drug Repurposing Encyclopedia (DRE): A web server for systematic drug repurposing across 20 organisms
X Li, L Pan, L Sanchez-Burgos, D Hühn, O Fernandez-Capetillo
BioRxiv, 2023.03. 10.532084, 2023
32023
The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγ
X Li, I Hernandez, S Koyuncu, B Kis, M Häggblad, L Lidemalm, AA Abbas, ...
EBioMedicine 103, 2024
22024
New regulators of the tetracycline‐inducible gene expression system identified by chemical and genetic screens
V Colicchia, M Häggblad, O Sirozh, B Porebski, M Balan, X Li, ...
FEBS Open bio 12 (10), 1896-1908, 2022
22022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20